RGD Reference Report - Polymorphism in intron 23 of the endothelial nitric oxide synthase gene (NOS3) is not associated with hypertension. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Polymorphism in intron 23 of the endothelial nitric oxide synthase gene (NOS3) is not associated with hypertension.

Authors: Derebecka, N  Holysz, M  Dankowski, R  Wierzchowiecki, M  Trzeciak, WH 
Citation: Derebecka N, etal., Acta Biochim Pol. 2002;49(1):263-8.
RGD ID: 1580281
Pubmed: PMID:12136949   (View Abstract at PubMed)

Nitric oxide (NO) is synthesised in the vascular endothelium by nitric oxide synthase (NOS3) and is an important factor in the regulation of blood pressure. Impaired synthesis of NO due to mutations in the NOS3 gene is associated with hypertension. To date several allelic variants of the NOS3 gene have been identified and their possible linkage with hypertension investigated. We studied the distribution of genotypes and frequency of alleles of the G11T polymorphism in intron 23 of the NOS3 gene in patients with hypertension and in a control group of healthy individuals. The polymorphism was determined by PCR-RFLP analysis. The distribution of genotypes in the patients with hypertension and in the healthy individuals did not differ significantly from the values predicted from Hardy-Weinberg equilibrium for the general population. No major differences in the distribution of the G11T polymorphism in the patients and healthy individuals were found (P > 0.05).

Objects referenced in this article
Gene NOS3 nitric oxide synthase 3 Homo sapiens
Gene Nos3 nitric oxide synthase 3, endothelial cell Mus musculus
Gene Nos3 nitric oxide synthase 3 Rattus norvegicus

Additional Information